These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1568524)

  • 41. Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics with clinical diabetic nephropathy.
    Hanssen KF; Svendsen PA; Evrin PE
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):75-86. PubMed ID: 4406483
    [No Abstract]   [Full Text] [Related]  

  • 42. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
    Wu CC; Chen JS; Lu KC; Chen CC; Lin SH; Chu P; Sytwu HK; Lin YF
    Clin Chim Acta; 2010 May; 411(9-10):700-4. PubMed ID: 20138168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
    Sinsakul M; Sika M; Rodby R; Middleton J; Shyr Y; Chen H; Han E; Lehrich R; Clyne S; Schulman G; Harris R; Lewis J
    Am J Kidney Dis; 2007 Dec; 50(6):946-51. PubMed ID: 18037095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin E1 for renal papillary necrosis in a patient with diabetes mellitus.
    Abe K; Ozono Y; Miyazaki M; Furusu A; Shioshita K; Sasaki O; Tsukasaki S; Harada T; Kohno S
    J Int Med Res; 1999; 27(2):90-5. PubMed ID: 10446696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of proteinuria in non-insulin dependent diabetes.
    Vijay V; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1994 Oct; 42(10):792-4. PubMed ID: 7876049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unbound and transthyretin-bound retinol-binding protein in serum and urine from diabetic patients with nephropathy and proteinuria.
    Holm J; Hemmingsen L
    Clin Chem; 1990 Nov; 36(11):1993-4. PubMed ID: 2242589
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of prostaglandin E1 on experimental acute hepatic failure in rabbits: prostaglandin E1 prevents the development of multiple-organ failure.
    Kikuchi E; Fukui H; Matsumoto M; Tsujita S; Matsumoto M; Matsumura M; Uemura M; Tsujii T
    J Hepatol; 1994 Apr; 20(4):478-82. PubMed ID: 8051385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antithrombin III and fibrinogen degradation product (fragment E) in diabetic nephropathy.
    Chan V; Yeung CK; Chan TK
    J Clin Pathol; 1982 Jun; 35(6):661-6. PubMed ID: 7085916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation analysis of urine proteins and inflammatory cytokines with osteoporosis in patients with diabetic nephropathy.
    Zhao Z
    J Musculoskelet Neuronal Interact; 2018 Sep; 18(3):348-353. PubMed ID: 30179212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immediate improvement of diabetic mononeuropathy after intravenous administration of prostaglandin E1.
    Shimizu H; Shimomura Y; Inukai T; Takahashi M; Uehara Y; Kobayashi I; Kobayashi S
    Jpn J Med; 1990; 29(2):222-5. PubMed ID: 2232371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterisation of diabetic proteinuria.
    Myer R; Marshall W; Jones RH; Parsons V; Watkins P
    Ric Clin Lab; 1980; 10(1):143-8. PubMed ID: 7466154
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of captopril on diabetic proteinuria.
    N Engl J Med; 1986 Aug; 315(8):515-6. PubMed ID: 3526154
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.
    Navarro JF; Mora C
    Diabetes Care; 1999 Jun; 22(6):1006-8. PubMed ID: 10372263
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma mature form of adrenomedullin in diabetic nephropathy.
    Kinoshita H; Fujimoto S; Tokura T; Hisanaga S; Kitamura K; Eto T
    Intern Med; 2001 Aug; 40(8):841-2. PubMed ID: 11518140
    [No Abstract]   [Full Text] [Related]  

  • 56. Proteinuria in diabetes.
    Mackintosh D; Viberti GC; Keen H
    Diabetologia; 1983 Apr; 24(4):304. PubMed ID: 6862135
    [No Abstract]   [Full Text] [Related]  

  • 57. Relief of causalgia with prostaglandin E1 ointment.
    Mashimo T; Tomi K; Pak M; Demizu A; Yoshiya I
    Anesth Analg; 1991 May; 72(5):700-1. PubMed ID: 2018228
    [No Abstract]   [Full Text] [Related]  

  • 58. Tubular proteinuria in diabetic children. A 3-year follow-up study.
    Ginevri F; Picotti E; Alinovi R; DeToni T; Bocchi CM; Mazzarello I; Perfumo F; Ghiggeri GM; Gusmano R
    Contrib Nephrol; 1993; 101():121-6. PubMed ID: 8467664
    [No Abstract]   [Full Text] [Related]  

  • 59. Blood rheology and diabetic nephropathy.
    Simpson LO
    Diabetologia; 1990 Sep; 33(9):576-7. PubMed ID: 2253836
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of prostaglandin E1 on slight proteinuria in non-azotaemic diabetics.
    Okada S; Sato K; Higuchi T; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1992 Feb; 20(1):94-7. PubMed ID: 1568524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.